Literature DB >> 25535667

Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.

Yuejie Chen1, Chengyu Liu, Zhen Chen, Ching Su, Michael Hageman, Munir Hussain, Roy Haskell, Kevin Stefanski, Feng Qian.   

Abstract

The in vitro dissolution mechanism of an amorphous solid dispersion (ASD) remains elusive and highly individualized, yet rational design of ASDs with optimal performance and prediction of their in vitro/in vivo performance are very much desirable in the pharmaceutical industry. To this end, we carried out comprehensive investigation of various ASD systems of griseofulvin, felodipine, and ketoconazole, in PVP-VA or HPMC-AS at different drug loading. Physiochemical properties and processes related to drug-polymer-water interaction, including the drug crystallization tendency in aqueous medium, drug-polymer interaction before and after moisture exposure, supersaturation of drug in the presence of polymer, polymer dissolution kinetics, etc., were characterized and correlated with the dissolution performance of ASDs at different dose and different drug/polymer ratio. It was observed that ketoconazole/HPMC-AS ASD outperformed all other ASDs in various dissolution conditions, which was attributed to the drug's low crystallization tendency, the strong ketoconazole/HPMC-AS interaction and the robustness of this interaction against water disruption, the dissolution rate and the availability of HPMC-AS in solution, and the ability of HPMC-AS in maintaining ketoconazole supersaturation. It was demonstrated that all these properties have implications for the dissolution performance of various ASD systems, and further quantification of them could be used as potential predictors for in vitro dissolution of ASDs. For all ASDs investigated, HPMC-AS systems performed better than, or at least comparably with, their PVP-VA counterparts, regardless of the drug loading or dose. This observation cannot be solely attributed to the ability of HPMC-AS in maintaining drug supersaturation. We also conclude that, for fast crystallizers without strong drug-polymer interaction, the only feasible option to improve dissolution might be to lower the dose and the drug loading in the ASD. In this study, we implemented an ASD/water Flory-Huggins parameter plot, which might assist in revealing the physical nature of the drug-polymer interaction. We also introduced supersaturation parameter and dissolution performance parameter as two quantitative measurements to compare the abilities of polymers in maintaining drug supersaturation, and the dissolution performance of various solid dispersions, respectively.

Entities:  

Keywords:  FT-IR; Flory−Huggins interaction parameter; NMR; amorphous solid dispersion; crystallization; dissolution; drug−polymer interaction; dynamic vapor sorption

Mesh:

Substances:

Year:  2015        PMID: 25535667     DOI: 10.1021/mp500660m

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  18 in total

Review 1.  Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.

Authors:  Jinjiang Li; Dhaval Patel; George Wang
Journal:  AAPS J       Date:  2016-11-28       Impact factor: 4.009

2.  Investigation of Polymer-Surfactant and Polymer-Drug-Surfactant Miscibility for Solid Dispersion.

Authors:  Suhas G Gumaste; Simerdeep Singh Gupta; Abu T M Serajuddin
Journal:  AAPS J       Date:  2016-06-14       Impact factor: 4.009

3.  Impact of Surfactants on the Performance of Clopidogrel-Copovidone Amorphous Solid Dispersions: Increased Drug Loading and Stabilization of Nanodroplets.

Authors:  Clara E Correa Soto; Yi Gao; Anura S Indulkar; Keisuke Ueda; Geoff G Z Zhang; Lynne S Taylor
Journal:  Pharm Res       Date:  2022-01-10       Impact factor: 4.200

Review 4.  Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.

Authors:  Qin Shi; Fang Li; Stacy Yeh; Sakib M Moinuddin; Junbo Xin; Jia Xu; Hao Chen; Bai Ling
Journal:  AAPS PharmSciTech       Date:  2021-12-10       Impact factor: 3.246

5.  The inhibiting role of hydroxypropylmethylcellulose acetate succinate on piperine crystallization to enhance its dissolution from its amorphous solid dispersion and permeability.

Authors:  Yueyi Deng; Qi Liang; Yiru Wang; Xiaolan Zhang; Chengyun Yan; Yulin He
Journal:  RSC Adv       Date:  2019-12-03       Impact factor: 4.036

6.  Poly (n-butyl cyanoacrylate) as a nanocarrier for rivastigmine transport across the blood-brain barrier in Alzheimer's disease treatment: a perspective from molecular dynamics simulations.

Authors:  Seyed Vahid Mousavi; Seyed Majid Hashemianzadeh
Journal:  J Mol Model       Date:  2018-08-25       Impact factor: 1.810

7.  Effervescence Assisted Fusion Technique to Enhance the Solubility of Drugs.

Authors:  Mohd Aftab Alam; Fahad I Al-Jenoobi; Abdullah M Al-Mohizea; Raisuddin Ali
Journal:  AAPS PharmSciTech       Date:  2015-08-12       Impact factor: 3.246

8.  Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.

Authors:  Yuejie Chen; Shujing Wang; Shan Wang; Chengyu Liu; Ching Su; Michael Hageman; Munir Hussain; Roy Haskell; Kevin Stefanski; Feng Qian
Journal:  Pharm Res       Date:  2016-06-09       Impact factor: 4.200

9.  Molecular mechanism of polymer-assisting supersaturation of poorly water-soluble loratadine based on experimental observations and molecular dynamic simulations.

Authors:  Shenwu Zhang; Mengchi Sun; Yongshan Zhao; Xuyang Song; Zhonggui He; Jian Wang; Jin Sun
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

10.  Development of micro-fibrous solid dispersions of poorly water-soluble drugs in sucrose using temperature-controlled centrifugal spinning.

Authors:  Stefania Marano; Susan Anne Barker; Bahijja Tolulope Raimi-Abraham; Shahrzad Missaghi; Ali Rajabi-Siahboomi; Duncan Q M Craig
Journal:  Eur J Pharm Biopharm       Date:  2016-03-21       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.